Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal UBE2D3 antibody. N-terminal. Suitable for IP, WB and reacts with Human samples. Cited in 10 publications.
View Alternative Names
UBC5C, UBCH5C, UBE2D3, Ubiquitin-conjugating enzyme E2 D3, (E3-independent) E2 ubiquitin-conjugating enzyme D3, E2 ubiquitin-conjugating enzyme D3, Ubiquitin carrier protein D3, Ubiquitin-conjugating enzyme E2(17)KB 3, Ubiquitin-conjugating enzyme E2-17 kDa 3, Ubiquitin-protein ligase D3
- IP
Supplier Data
Immunoprecipitation - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (AB176568)
Western blot analysis on immunoprecipitation pellet from 293T cell lysate labeling UBE2D3 with ab176568 at 1/10 dilution.
All lanes:
Immunoprecipitation - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (ab176568)
Predicted band size: 16 kDa
true
- WB
Supplier Data
Western blot - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (AB176568)
All lanes:
Western blot - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (ab176568) at 1/1000 dilution
Lane 1:
MCF7 cell lysate at 10 µg
Lane 2:
Jurkat cell lysate at 10 µg
Lane 3:
293T cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 16 kDa
true
- WB
CiteAb
Western blot - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (AB176568)
UBE2D3 western blot using anti-UBE2D3 antibody [EPR13001(B)] - N-terminal ab176568. Publication image and figure legend from Shi, Y., Yuan, B., et al., 2017, Nat Commun, PubMed 28469175.
ab176568 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab176568 please see the product overview.
Ub2D3 and Ube2N are required for RIG-I and MAVS activation on virus infection in HEK293T cells.(a,b) The cell-free assay containing vRNA and purified components (E1, Ub, RIG-I and Riplet) was performed as described in Fig. 2b, except that S100 fraction was substituted with purified E2 recombinant proteins as indicated. Each E2 protein was analysed at three different concentrations. Lane 13 did not contain E2 proteins (-E2). (c) HEK293T cells (wild-type and knockout lines) were transfected with or without si-Ube2D3 RNAs. Seventy two hours after transfection, the cells were infected with VSV. Twelve hours post virus infection, the cells were collected for measuring IFN induction by qPCR. *p<0.05 and ***p<0.001. (d,e) Cells were treated as described in c. P5 fractions were isolated to examine MAVS aggregation (d), and whole cell lysate were used to analyse knockdown or knockout effect in genes as indicated (e). The original full blot for (e) can be found in Supplementary Fig. 8d. (f) si-Ube2D3 RNAs were transfected into HEK293T (Ube2N-/-) cells. Seventy two hours after siRNA transfection, the cells were further transfected with pcDNA-flag-Ube2D3 or pcDNA-flag-Ube2N as indicated. Twenty four hours after transfection of pcDNA plasmids, the cells were infected with VSV for another twelve hours. The cells were then collected for analysis of MAVS aggregation. See also Supplementary Fig. 3f.
false
Related conjugates and formulations (1)
-
Anti-UBE2D3 antibody [EPR13001(B)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
UBE2D3 acts as an important component in protein degradation and regulation. It participates in the ubiquitin-proteasome system which controls protein levels in cells. UBE2D3 forms part of larger protein complexes such as the SCF (Skp Cullin F-box containing) complex contributing to the regulation of cell cycle and signal transduction. This interaction helps control cell division and response to external signals.
Pathways
UBE2D3 plays an important role in the NF-kB signaling and DNA damage response pathways. It interacts with proteins such as IKK (IκB kinase) to regulate inflammation and immune response. Additionally UBE2D3's involvement in the DNA repair pathway supports maintaining genome stability by collaborating with other proteins like BRCA1 which is essential for repairing DNA double-strand breaks.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:7359 PubMed39198387
2024
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:1089-1109 PubMed38360992
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 29:162 PubMed38041015
2023
Applications
Unspecified application
Species
Unspecified reactive species
ACS chemical biology 18:897-904 PubMed36940189
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell chemical biology 30:394-402.e9 PubMed36898369
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:674286 PubMed34195079
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:667435 PubMed33996822
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 8:15138 PubMed28469175
2017
Applications
WB
Species
Human
Journal of immunology (Baltimore, Md. : 1950) 198:820-831 PubMed27986908
2016
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 7:1152-62 PubMed27326259
2016
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com